West Pharmaceutical Services Total Assets 2012-2025 | WST
West Pharmaceutical Services total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- West Pharmaceutical Services total assets for the quarter ending September 30, 2025 were $4.106B, a 11.72% increase year-over-year.
- West Pharmaceutical Services total assets for 2024 were $3.643B, a 4.86% decline from 2023.
- West Pharmaceutical Services total assets for 2023 were $3.83B, a 5.88% increase from 2022.
- West Pharmaceutical Services total assets for 2022 were $3.617B, a 9.14% increase from 2021.
|
West Pharmaceutical Services Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $3,643 |
| 2023 | $3,830 |
| 2022 | $3,617 |
| 2021 | $3,314 |
| 2020 | $2,794 |
| 2019 | $2,341 |
| 2018 | $1,979 |
| 2017 | $1,863 |
| 2016 | $1,717 |
| 2015 | $1,695 |
| 2014 | $1,670 |
| 2013 | $1,672 |
| 2012 | $1,564 |
| 2011 | $1,399 |
|
West Pharmaceutical Services Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-09-30 | $4,106 |
| 2025-06-30 | $3,953 |
| 2025-03-31 | $3,618 |
| 2024-12-31 | $3,643 |
| 2024-09-30 | $3,675 |
| 2024-06-30 | $3,489 |
| 2024-03-31 | $3,602 |
| 2023-12-31 | $3,830 |
| 2023-09-30 | $3,755 |
| 2023-06-30 | $3,670 |
| 2023-03-31 | $3,724 |
| 2022-12-31 | $3,617 |
| 2022-09-30 | $3,317 |
| 2022-06-30 | $3,362 |
| 2022-03-31 | $3,295 |
| 2021-12-31 | $3,314 |
| 2021-09-30 | $3,143 |
| 2021-06-30 | $2,934 |
| 2021-03-31 | $2,740 |
| 2020-12-31 | $2,794 |
| 2020-09-30 | $2,583 |
| 2020-06-30 | $2,392 |
| 2020-03-31 | $2,247 |
| 2019-12-31 | $2,341 |
| 2019-09-30 | $2,174 |
| 2019-06-30 | $2,123 |
| 2019-03-31 | $2,036 |
| 2018-12-31 | $1,979 |
| 2018-09-30 | $1,946 |
| 2018-06-30 | $1,874 |
| 2018-03-31 | $1,870 |
| 2017-12-31 | $1,863 |
| 2017-09-30 | $1,930 |
| 2017-06-30 | $1,843 |
| 2017-03-31 | $1,734 |
| 2016-12-31 | $1,717 |
| 2016-09-30 | $1,735 |
| 2016-06-30 | $1,705 |
| 2016-03-31 | $1,668 |
| 2015-12-31 | $1,695 |
| 2015-09-30 | $1,667 |
| 2015-06-30 | $1,664 |
| 2015-03-31 | $1,596 |
| 2014-12-31 | $1,670 |
| 2014-09-30 | $1,673 |
| 2014-06-30 | $1,705 |
| 2014-03-31 | $1,708 |
| 2013-12-31 | $1,672 |
| 2013-09-30 | $1,665 |
| 2013-06-30 | $1,613 |
| 2013-03-31 | $1,577 |
| 2012-12-31 | $1,564 |
| 2012-09-30 | $1,527 |
| 2012-06-30 | $1,463 |
| 2012-03-31 | $1,457 |
| 2011-12-31 | $1,399 |
| 2011-09-30 | $1,398 |
| 2011-06-30 | $1,415 |
| 2011-03-31 | $1,366 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $18.022B | $2.893B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $101.437B | 22.66 |
| Becton Dickinson (BDX) | United States | $57.947B | 14.10 |
| Cardinal Health (CAH) | United States | $49.983B | 23.61 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.517B | 0.00 |
| Cooper (COO) | United States | $15.798B | 19.52 |
| Align Technology (ALGN) | United States | $11.878B | 22.43 |
| Henry Schein (HSIC) | United States | $9.151B | 16.13 |
| Merit Medical Systems (MMSI) | United States | $4.844B | 23.82 |
| DENTSPLY SIRONA (XRAY) | United States | $2.404B | 7.63 |
| CONMED (CNMD) | United States | $1.289B | 9.21 |
| STAAR Surgical (STAA) | United States | $1.043B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.136B | 16.24 |
| Lifevantage (LFVN) | United States | $0.076B | 7.24 |
| Axe Compute (AGPU) | United States | $0.020B | 0.00 |